{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:56:54Z","timestamp":1790639814283,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-026-04781-7","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T06:30:26Z","timestamp":1790577026000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sex differences in the clinical presentation and complications of primary hyperparathyroidism: insights from a single-center cohort study"],"prefix":"10.1007","volume":"91","author":[{"given":"Ruggeri Rosaria","family":"Maddalena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lagan\u00e0","family":"Martina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scalise","family":"Serena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiano","family":"Cristina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alibrandi","family":"Angela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Campenn\u00ec","family":"Alfredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cannav\u00f2","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"4781_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s40618-015-0261-3","volume":"38","author":"C Marcocci","year":"2015","unstructured":"C. Marcocci, M.L. Brandi, A. Scillitani, S. Corbetta, A. Faggiano, L. Gianotti et al., Italian Society of Endocrinology Consensus Statement: definition, evaluation and management of patients with mild primary hyperparathyroidism. J. Endocrinol. Invest. 38, 577\u2013593 (2015). https:\/\/doi.org\/10.1007\/s40618-015-0261-3","journal-title":"J. Endocrinol. Invest."},{"key":"4781_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(17","volume":"391","author":"JP Bilezikian","year":"2018","unstructured":"J.P. Bilezikian, L. Bandeira, A. Khan et al., Hyperparathyroidism Lancet. 391, 168\u2013178 (2018). https:\/\/doi.org\/10.1016\/S0140-6736(17","journal-title":"Hyperparathyroidism Lancet"},{"issue":"1","key":"4781_CR3","first-page":"1","volume":"10","author":"O Vandenbulcke","year":"2014","unstructured":"O. Vandenbulcke, P. Delaere, V. Vander Poorten, F. Debruyne, Incidence of multiglandular disease in sporadic primary hyperparathyroidism. B-ENT. 10(1), 1\u20136 (2014)","journal-title":"B-ENT"},{"issue":"6","key":"4781_CR4","doi-asserted-by":"publisher","first-page":"e2215396","DOI":"10.1001\/jamanetworkopen.2022.15396","volume":"5","author":"KF Axelsson","year":"2022","unstructured":"K.F. Axelsson, M. Wallander, H. Johansson et al., Analysis of co morbidities, clinical outcomes, and parathyroidectomy in adults with primary hyperparathyroidism. JAMA Netw. Open. 5(6), e2215396 (2022). https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.15396","journal-title":"JAMA Netw. Open."},{"issue":"6","key":"4781_CR5","doi-asserted-by":"publisher","first-page":"812","DOI":"10.7326\/M21-4416","volume":"175","author":"M Pretorius","year":"2022","unstructured":"M. Pretorius, K. Lundstam, A. Heck et al., Mortality and morbidity in mild primary hyperparathyroidism: results from a 10-year prospective randomized controlled trial of parathyroidectomy versus observation. Ann. Intern. Med. 175(6), 812\u2013819 (2022). https:\/\/doi.org\/10.7326\/M21-4416","journal-title":"Ann. Intern. Med."},{"key":"4781_CR6","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.bone.2014.12.067","volume":"74","author":"PB Clifton-Bligh","year":"2015","unstructured":"P.B. Clifton-Bligh, M.L. Nery, R. Supramaniam et al., Mortality associated with primary hyperparathyroidism. Bone. 74, 121\u2013124 (2015). https:\/\/doi.org\/10.1016\/j.bone.2014.12.067","journal-title":"Bone"},{"key":"4781_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2014.12.003","volume":"73","author":"ML Griebeler","year":"2015","unstructured":"M.L. Griebeler, A.E. Kearns, E. Ryu, M.A. Hathcock, L.J. 3 Melton rd, R.A. Wermers, Secular trends in the incidence of primary hyperparathyroidism over five decades (1965\u20132010). Bone. 73, 1\u20137 (2015). https:\/\/doi.org\/10.1016\/j.bone.2014.12.003","journal-title":"Bone"},{"issue":"3","key":"4781_CR8","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","volume":"98","author":"MW Yeh","year":"2013","unstructured":"M.W. Yeh, P.H. Ituarte, H.C. Zhou et al., Incidence and prevalence of primary hyperparathyroidism in a racially mixed population. J. Clin. Endocrinol. Metab. 98(3), 1122\u20131129 (2013). https:\/\/doi.org\/10.1210\/jc.2012-4022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4781_CR9","doi-asserted-by":"publisher","unstructured":"S. Minisola, A. Arnold, Z. Belaya, M.L. Brandi, B.L. Clarke, F.M. Hannan et al., Epidemiology, Pathophysiology, and Genetics of Primary Hyperparathyroidism. J BoneMiner Res. 1;37(11), 2315\u20132329 (2020) https:\/\/doi.org\/10.1002\/jbmr.4665","DOI":"10.1002\/jbmr.4665"},{"issue":"10","key":"4781_CR10","doi-asserted-by":"publisher","first-page":"e1117","DOI":"10.1210\/clinem\/dgad201","volume":"108","author":"E Soto-Pedre","year":"2023","unstructured":"E. Soto-Pedre, P.J. Newey, G.P. Leese, Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in Scotland. J. Clin. Endocrinol. Metab. 108(10), e1117\u20131124 (2023). https:\/\/doi.org\/10.1210\/clinem\/dgad201","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"4781_CR11","doi-asserted-by":"publisher","first-page":"4631","DOI":"10.1210\/jc.2012-2484","volume":"97","author":"F Haglund","year":"2012","unstructured":"F. Haglund, R. Ma, M. Huss et al., Evidence of a functional estrogen receptor in parathyroid adenomas. J. Clin. Endocrinol. Metab. 97(12), 4631\u20134639 (2012). https:\/\/doi.org\/10.1210\/jc.2012-2484","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"4781_CR12","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/cells8010015","volume":"8","author":"MP Yavropoulou","year":"2018","unstructured":"M.P. Yavropoulou, C. Poulios, N. Michalopoulos et al., A role for circular non-coding RNAs in the pathogenesis of sporadic parathyroid adenomas and the impact of gender-specific epigenetic regulation. Cells. 8(1), 15 (2018). https:\/\/doi.org\/10.3390\/cells8010015","journal-title":"Cells"},{"issue":"5","key":"4781_CR13","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1177\/1759720X12441869","volume":"4","author":"C Marcocci","year":"2012","unstructured":"C. Marcocci, L. Cianferotti, F. Cetani, Bone disease in primary hyperparathyrodism. Ther. Adv. Musculoskelet. Dis. 4(5), 357\u2013368 (2012). https:\/\/doi.org\/10.1177\/1759720X12441869","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"issue":"6","key":"4781_CR14","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3275\/7861","volume":"35","author":"D Han","year":"2012","unstructured":"D. Han, S. Trooskin, X. Wang, Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism. J. Endocrinol. Invest. 35(6), 548\u2013552 (2012). https:\/\/doi.org\/10.3275\/7861","journal-title":"J. Endocrinol. Invest."},{"issue":"11","key":"4781_CR15","doi-asserted-by":"publisher","first-page":"4148","DOI":"10.1210\/jc.2017-01080","volume":"102","author":"E Castellano","year":"2017","unstructured":"E. Castellano, R. Attanasio, A. Boriano, M. Pellegrino, F. Garino, L. Gianotti et al., Sex difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status. J. Clin. Endocrinol. Metab. 102(11), 4148\u20134152 (2017). https:\/\/doi.org\/10.1210\/jc.2017-01080","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4781_CR16","doi-asserted-by":"publisher","unstructured":"D.M. Vodopivec, A.M. Silva, D.C. Garcia-Banigan, I. Christakis, A. Stewart, K. Schwarz et al., Gender differences in bone mineral density in patients with sporadic primary hyperparathyroidism. Endocrinol. Diabetes Metab. 1(4) (2018). https:\/\/doi.org\/10.1002\/edm2.37. e00037Sep","DOI":"10.1002\/edm2.37"},{"issue":"9","key":"4781_CR17","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1245\/s10434-012-2378-3","volume":"19","author":"H Mazeh","year":"2012","unstructured":"H. Mazeh, R.S. Sippel, H. Chen, The role of gender in primary hyperparathyroidism: same disease, different presentation. Ann. Surg. Oncol. 19(9), 2958\u20132962 (2012). https:\/\/doi.org\/10.1245\/s10434-012-2378-3","journal-title":"Ann. Surg. Oncol."},{"issue":"2","key":"4781_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3275\/8455","volume":"36","author":"F DeLucia","year":"2013","unstructured":"F. DeLucia, S. Minisola, E. Romagnoli, J. Pepe, C. Cipriani, A. Scillitani, N. Parikh, D.S. Rao, Effect of gender and geographic location on the expression of primary hyperparathyroidism. J. Endocrinol. Invest. 36(2), 123\u2013126 (2013). https:\/\/doi.org\/10.3275\/8455","journal-title":"J. Endocrinol. Invest."},{"key":"4781_CR19","doi-asserted-by":"publisher","unstructured":"J.P. Bilezikian, A.A. Khan, S.J. Silverberg, G.E. Fuleihan, C. Marcocci, S. Minisola et al., Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the Fifth International Workshop. J Bone Miner Res. (2022) 37, 2293\u20132314 https:\/\/doi.org\/10.1002\/jbmr.4677","DOI":"10.1002\/jbmr.4677"},{"key":"4781_CR20","unstructured":"World Health Organization. Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation. Geneva: World Health Organization, 2000. WHO Technical Report Series No. 894"},{"issue":"1","key":"4781_CR21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1089\/heq.2023.0038","volume":"8","author":"K Charles","year":"2024","unstructured":"K. Charles, M.J. Lewis, E. Montgomery, M. Reid, The 2021 Chronic Kidney Disease Epidemiology Collaboration Race-Free Estimated Glomerular Filtration Rate Equations in Kidney Disease: Leading the Way in Ending Disparities. Health Equity. 8(1), 39\u201345 (2024). https:\/\/doi.org\/10.1089\/heq.2023.0038","journal-title":"Health Equity"},{"key":"4781_CR22","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1002\/jbmr.5650110716","volume":"11","author":"HK Genant","year":"1996","unstructured":"H.K. Genant, M. Jergas, L. Palermo, M. Nevitt, R.S. Valentin, D. Black et al., Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group. J. BoneMiner Res. 11, 984\u2013996 (1996). https:\/\/doi.org\/10.1002\/jbmr.5650110716","journal-title":"J. BoneMiner Res."},{"issue":"3","key":"4781_CR23","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12020-023-03331-9","volume":"80","author":"L di Filippo","year":"2023","unstructured":"di L. Filippo, M. Uygur, M. Locatelli, F. Nannipieri, S. Frara, A. Giustina, Low vitamin D levels predict outcomes of COVID\u201319 in patients with both severe and non-severe disease at hospitalization. Endocrine. 80(3), 669\u2013683 (2023). https:\/\/doi.org\/10.1007\/s12020-023-03331-9","journal-title":"Endocrine"},{"issue":"1","key":"4781_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1159\/000505497","volume":"36","author":"T Weber","year":"2020","unstructured":"T. Weber, A. Hillenbrand, S. Peth, R. Hummel, Symptoms of Primary Hyperparathyroidism in Men and Women: The Same but Different? Visc. Med. 36(1), 41\u201347 (2020). https:\/\/doi.org\/10.1159\/000505497","journal-title":"Visc. Med."},{"key":"4781_CR25","unstructured":"V.N. Shah, S.K. Bhadada, A. Bhansali, A. Behera, A. Bhattacharya, U. Nahar et al., Effect of gender, biochemical parameters & parathyroid surgery on gastrointestinal manifestations of symptomatic primary hyperparathyroidism 139(2), 279\u2013284 (2014)"},{"key":"4781_CR26","doi-asserted-by":"publisher","unstructured":"M. Corbetta, S. Carrara, A. Dal Lago, R. Mirsepanj, E. Ruotolo, C. Sardella, G. Leo, F. Cetani, S. Corbetta, Effects of Gender, Menopause, Vitamin D Status, and Tumor Parathyroid Cell Activity on Serum Phosphate Levels in a Large Cohort of Patients with Sporadic Hypercalcemic Primary Hyperparathyroidism. Int. J. Mol. Sci. 27(4) (2026). https:\/\/doi.org\/10.3390\/ijms27042012","DOI":"10.3390\/ijms27042012"},{"issue":"4","key":"4781_CR27","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s11154-021-09693-7","volume":"22","author":"JP Bilezikian","year":"2021","unstructured":"J.P. Bilezikian, A.M. Formenti, R.A. Adler, N. Binkley, R. Bouillon, M. Lazaretti-Castro, C. Marcocci, N. Napoli, R. Rizzoli, A. Giustina, D. Vitamin, Dosing, levels, form, and route of administration: Does one approach fit all? Rev. Endocr. Metab. Disord. 22(4), 1201\u20131218 (2021). https:\/\/doi.org\/10.1007\/s11154-021-09693-7","journal-title":"Rev. Endocr. Metab. Disord"},{"issue":"8","key":"4781_CR28","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s40618-020-01473-5","volume":"44","author":"A Song","year":"2021","unstructured":"A. Song, H. Zhao, Y. Yang, S. Liu, M. Nie, O. Wang, X. Xing, Safety and efficacy of common vitamin D supplementation in primary hyperparathyroidism and coexistent vitamin D deficiency and insufficiency: a systematic review and meta-analysis. J. Endocrinol. Invest. 44(8), 1667\u20131677 (2021). https:\/\/doi.org\/10.1007\/s40618-020-01473-5","journal-title":"J. Endocrinol. Invest."},{"issue":"8","key":"4781_CR29","doi-asserted-by":"publisher","first-page":"991","DOI":"10.2174\/0118715303260423231122111705","volume":"24","author":"F Vescini","year":"2024","unstructured":"F. Vescini, G. Borretta, I. Chiodini, M. Boniardi, M. Carotti, E. Castellano et al., Italian Guidelines for the Management of Sporadic Primary Hyperparathyroidism. Endocr. Metab. Immune Disord - Drug Targets. 24(8), 991\u20131006 (2024)","journal-title":"Endocr. Metab. Immune Disord - Drug Targets"},{"key":"4781_CR30","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.maturitas.2020.11.007","volume":"145","author":"T Dadon","year":"2021","unstructured":"T. Dadon, G. Tsvetov, S. Levi, A. Gorshtein, I. Slutzky-Shraga, D. Hirsch, Gender differences in the presentation, course and outcomes of primary hyperparathyroidism. Maturitas. 145, 12\u201317 (2021). https:\/\/doi.org\/10.1016\/j.maturitas.2020.11.007","journal-title":"Maturitas"},{"issue":"1","key":"4781_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/dmrr.637","volume":"23","author":"AA Khaleeli","year":"2007","unstructured":"A.A. Khaleeli, J.N. Johnson, W.H. Taylor, Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy. Diabetes Metab. Res. Rev. 23(1), 43\u201348 (2007). https:\/\/doi.org\/10.1002\/dmrr.637","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"69","key":"4781_CR32","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1530\/EJE-13-0547","volume":"169","author":"S Norenstedt","year":"2013","unstructured":"S. Norenstedt, Y. Pernow, K. Brismar et al., Primary hyperparathyroidism and metabolic risk factors, impact of parathyroidectomy and vitamin D supplementation, and results of a randomized double-blind study. Eur. J. Endocrinol. 169(69), 795\u2013804 (2013). https:\/\/doi.org\/10.1530\/EJE-13-0547","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"4781_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1046\/j.0300-0664.2001.01468.x","volume":"56","author":"E Hagstr\u00f6m","year":"2002","unstructured":"E. Hagstr\u00f6m, E. Lundgren, H. Lithell et al., Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clin. Endocrinol. (Oxf). 56(2), 253\u2013260 (2002). https:\/\/doi.org\/10.1046\/j.0300-0664.2001.01468.x","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"6","key":"4781_CR34","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s40618-023-02018-2","volume":"46","author":"R Modica","year":"2023","unstructured":"R. Modica, A. Liccardi, R. Minotta, E. Benevento, G. Cannavale, A. Colao, Parathyroid diseases and metabolic syndrome. J. Endocrinol. Invest. 46(6), 1065\u20131077 (2023). https:\/\/doi.org\/10.1007\/s40618-023-02018-2","journal-title":"J. Endocrinol. Invest."},{"issue":"3","key":"4781_CR35","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/01.cir.98.3.256","volume":"98","author":"JD Marsh","year":"1998","unstructured":"J.D. Marsh, M.H. Lehmann, R.H. Ritchie, J.K. Gwathmey, G.E. Green, R.J. Schiebinger, Androgen Receptors Mediate Hypertrophy in Cardiac Myocytes. Circulation. 98(3), 256\u2013261 (1998). https:\/\/doi.org\/10.1161\/01.cir.98.3.256","journal-title":"Circulation"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04781-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-026-04781-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-026-04781-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T23:02:02Z","timestamp":1790636522000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-026-04781-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4781"],"URL":"https:\/\/doi.org\/10.1007\/s12020-026-04781-7","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"assertion":[{"value":"12 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the local Ethics Committee (AOU Policlinico G. Martino, University of Messina) and that informed consent was obtained from each participant. The study in compliance with the ethical guiding principles and the World Medical Association\u2019s Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"310"}}